Registry-listed formulations

Macrogol · chembl:CHEMBL1201478

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

51 source entries across 46 studies. This list may not include all unresolved or historical entries.

  • Polyethylene Glycol PowderRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Polyethylene GlycolRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Polyethylene glycolRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Polyethylene GlycolsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • 3 L Polyethylene glycol solutionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Polyethylene GlycolRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Polyethylene GlycolsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • polyethylene glycolRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Polyethylene GlycolsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Polyethylene GlycolsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • polyethylene glycolRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 30 completed trials

Completion Rate
91%(30/33)
Active Trials
1(2%)
Results Posted
10%(3 trials)
Terminated
3(6%)

Phase Distribution

Phase 1
1
2%
Phase 2/3
1
2%
Phase 1/2
1
2%
Phase 3
7
15%
Phase 4
22
47%
Not Applicable
13
28%

Phase Distribution

1

Early Stage

2

Mid Stage

29

Late Stage

Phase Distribution45 total trials
Phase 1Safety & dosage
1(2.2%)
Phase 1/2Combined phases
1(2.2%)
Phase 2/3Combined phases
1(2.2%)
Phase 3Large-scale testing
7(15.6%)
Phase 4Post-market surveillance
22(48.9%)
N/ANon-phased studies
13(28.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

30 of 33 finished

Non-Completion Rate

9.1%

3 ended early

Currently Active

1

trials recruiting

Total Trials

47

all time

Status Distribution
Active(1)
Completed(30)
Terminated(3)
Other(13)

Detailed Status

Completed30
unknown13
Terminated3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
47
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

Phase 11 (2.2%)
Phase 1/21 (2.2%)
Phase 2/31 (2.2%)
Phase 37 (15.6%)
Phase 422 (48.9%)
N/A13 (28.9%)

Trials by Status

completed3064%
unknown1328%
recruiting12%
terminated36%

Recent Activity

1 active trials
Showing 5 of 47
terminatedphase_1

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

NCT03236064
recruitingnot_applicable

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

NCT04199026
completedphase_4

Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

NCT04197869
completednot_applicable

Effect of MiniGo As Add-on to Oral Laxatives for Children with Constipation and Fecal Incontinence

NCT05570318
unknownnot_applicable

Comparative Study on the Efficacy of Vibrabot Capsule and Polyethylene Glycol for Chronic Functional Constipation

NCT06364111
View all 47 trials

Clinical Trials (47)

Showing 20 of 47 trialsScroll for more
NCT03236064Phase 1

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

Terminated
NCT04199026Not Applicable

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Recruiting
NCT04197869Phase 4

Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

Completed
NCT05570318Not Applicable

Effect of MiniGo As Add-on to Oral Laxatives for Children with Constipation and Fecal Incontinence

Completed
NCT06364111Not Applicable

Comparative Study on the Efficacy of Vibrabot Capsule and Polyethylene Glycol for Chronic Functional Constipation

Unknown
NCT06207721Not Applicable

Physical Therapy for Functional Constipation in Children

Completed
NCT05726097Phase 3

Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure

Completed
NCT05341180Phase 2/3

Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial

Completed
NCT05920213Phase 4

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Unknown
NCT04436601Phase 4

Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)

Unknown
NCT05076799Phase 3

Effect of Lactulose and/or Polyethylene Glycol Solution for Bowel Preparation for Colonscopy Procedures

Completed
NCT04434625Not Applicable

The Effect of a Predictive Model of Bowel Preparation Based on Procedure-related Factors

Completed
NCT04138004Phase 4

Colon Preparation With 2L PEG in Combination With Lubiprostone vs 4L PEG

Completed
NCT02956057Phase 4

Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy

Completed
NCT03395548Not Applicable

Stability of the Microbiome in IBD and IBS

Completed
NCT03817788Phase 4

Randomized Controlled Trail of Polyethylene Glycol vs Sodium Phosphate for Colonic Cleansing of Colonoscopy

Completed
NCT03830489Phase 4

Impact of a Predictive Score of Bowel Preparation Quality in Clinical Practice

Completed
NCT03704571Not Applicable

A Predictive Model for Inadequate Bowel Preparation

Completed
NCT03436719Not Applicable

Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

Unknown
NCT03495804Not Applicable

Evaluation of the Performance of Two Neutral Oral Contrast Agents in CT Enterography

Unknown

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
47

External References

ChEMBL
CHEMBL1201478

Names & Codes

ATC Classification

A06AD15A06AD65

Research Codes

E-1521INS NO.1521INS-1521